Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Daniel Bakal"'
Autor:
Adolph Ulfohn, Arnold M. Seligman, Olympia Aybar, Samuel Sass, Benjamin Witten, Samuel E. Gaby, Sheldon C. Kravitz, Jacob I. Miller, Albert Schilling, Daniel Bakal, Charles E Williamson, Stanley P. Kramer, Stanley Miller, Louis E. Goodman
Publikováno v:
Cancer. 16:727-736
Autor:
Charles E. Williamson, Jacob I. Miller, Samuel D. Gaby, Louis E. Goodman, Daniel Bakal, Samuel Sass, Arnold M. Seligman, Benjamin Witten, Robert D. Solomon, Stanley P. Kramer
Publikováno v:
Cancer. 15:1056-1061
Autor:
Samuel D. Gaby, Maria G. Ascoli, Kwan-Chung Tsou, Howard E. Dorfman, Louis E. Goodman, Stanley P. Kramer, Olimpia Aybar, Adolph Ulfohn, Daniel Bakal, Elena Cendana, Arnold M. Seligman
Publikováno v:
Cancer. 18:307-312
Publikováno v:
Annals of neurology. 11(5)
Solitary neoplastic proliferation of plasma cells (plasmacytoma) rarely occurs in the central nervous system. The longest follow-up in nine previously reported patients was 5 years. We have followed two patients with solitary intracranial plasmacytom
Autor:
Samuel Sass, Anselmo G. Mamaril, Benjamin Witten, Simon Calle, Arnold M. Seligman, Daniel Bakal, Charles E. Williamson, Louis E. Goodman, Belur S. Bhagavan, Yale H. Caplan, Adolph Ulfohn
Publikováno v:
The Journal of surgical research. 11(5)
Clinical trials of a new water-soluble short half-life alkylating agent (S-73) administered by intra-arterial infusion into 56 patients with a variety of malignant tumors, revealed only limited usefulness. The best responses were seen in a case of Ka
Autor:
Adolph Ulfohn, Louis E. Goodman, Arnold M. Seligman, Stanley P. Kramer, Charles E. Williamson, Rolando Madamba, Samuel Sass, Benjamin Witten, Simon Calle, Daniel Bakal
Publikováno v:
Cancer. 20(5)
This is a preliminary report on the experimental and clinical use of a new alkylating agent (S-73) which is water soluble, stable to hydrolysis for hours, but with esterase-susceptible linkages, which results in inactivation of the agent by esterase